- Home
- KOD vs PFN Comparison
KOD vs PFN Comparison
Compare KOD & PFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KOD | PFN |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 699.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KOD | PFN |
|---|---|---|
| Price | $26.05 | $7.45 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $26.57 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 331.7K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $5.94 |
| 52 Week High | $31.18 | $7.58 |
Technical Indicators
Market Signals| Indicator | KOD | PFN |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 51.93 |
| Support Level | $23.92 | $7.42 |
| Resistance Level | $28.11 | $7.46 |
| Average True Range (ATR) | 2.28 | 0.07 |
| MACD | -0.49 | 0.01 |
| Stochastic Oscillator | 27.41 | 51.87 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About PFN PIMCO Income Strategy Fund II
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund. The company's primary investment objective is to seek high current income, consistent with the preservation of capital. The fund invests in a range of securities, such as corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, municipal bonds and notes, short-term instruments, sovereign Issues, preferred Securities and others.